ZipRecruiter's Return on Invested Capital (ROIC) of -5.32% indicates it is not generating sufficient returns to cover its cost of capital.Clear Secure, Inc. (NYSE:YOU) stands out with a ROIC of 100.50%, significantly outperforming its peers.Both TaskUs, Inc. (NASDAQ:TASK) and FIGS, Inc. (NYSE:FIGS) show positive ROIC figures, though they still face challenges in surpassing their cost of capital.ZipRecruiter, Inc. (NYSE:ZIP) is a prominent online employment marketplace that connects job seekers with employer ...

Motorsport Games Inc. (NASDAQ:MSGM) has a ROIC of -28.03% and a WACC of 13.73%, indicating it is not generating sufficient returns to cover its cost of capital.Genius Group Limited (GNS) and other competitors also show negative ROIC to WACC ratios, but Magic Empire Global Limited (MEGL) is closest to covering its cost of capital.Mobile Global Esports Inc. (MGAM) displays the most significant inefficiencies in capital utilization with a ROIC to WACC ratio of -75.66.Motorsport Games Inc. (NASDAQ:MSGM) is a co ...

公司资本效率分析 - CF Bankshares Inc (CFBK) 的投入资本回报率(ROIC)为-1.19% 远低于其24.98%的加权平均资本成本(WACC) 显示资本使用效率严重低下 [2] - CFBK的ROIC与WACC比值为-0.048 表明公司未能有效利用资本创造回报 [2] 同业比较分析 - Citizens Community Bancorp (CZWI) ROIC为0.80% WACC为18.82% 比值为0.042 虽为正值但仍显示资本利用效率偏低 [3] - Colony Bankcorp (CBAN) ROIC为-0.63% WACC为12.69% 比值为-0.050 与CFBK类似存在资本效率问题 [3] - Community West Bancshares (CWBC) ROIC达4.54% WACC为11.57% 比值为0.392 资本效率表现良好 [4] - C&F Financial Corporation (CFFI) ROIC为6.28% WACC为13.55% 比值0.463为同业最高 资本回报效率最优 [4][5] 行业竞争格局 - 行业竞争对手包括Citizens Community Bancorp、Colony Bankcorp、Community West Bancshares、Citizens Holding Company及C&F Financial Corporation等金融机构 [1] - 行业普遍采用ROIC与WACC比较来衡量资本配置效率 [1]

Marchex, Inc. (NASDAQ:MCHX) is a company that specializes in call analytics and call tracking solutions, helping businesses connect, drive, and convert more customers. Despite its innovative services, Marchex faces challenges in financial efficiency. The company's Return on Invested Capital (ROIC) is -15.82%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 12.69%. This negative ROIC indicates that Marchex is not generating returns above its cost of capital, a concerning sign ...

ADC Therapeutics S.A. struggles with capital efficiency, having a Return on Invested Capital (ROIC) of -54.62% versus its Weighted Average Cost of Capital (WACC) of 20.44%.Ciena Corporation (CIEN) and Sanmina Corporation (SANM) show more favorable financial positions, with Sanmina achieving a ROIC that exceeds its WACC.COMSovereign Holding Corp. (COMS), Altair Engineering Inc. (ALTR), and ADTRAN Holdings, Inc. (ADTN) also face challenges in capital efficiency, with COMS showing severe inefficiencies.ADC The ...

Kaspi.kz boasts a remarkable ROIC of 41.90% significantly higher than its WACC of 4.59%.Comparatively, its competitors have lower ROIC to WACC ratios, indicating less efficiency in generating returns from invested capital.Kaspi.kz stands out with the highest ROIC to WACC ratio among its peers, showcasing superior capital utilization and return generation.Joint Stock Company Kaspi.kz (LSE:KSPI) is a prominent financial technology company based in Kazakhstan. It offers a range of services including payments, ...

SANUWAVE Health, Inc. (OTC:SNWV) is a pioneering company in the field of regenerative medicine, focusing on the development and commercialization of non-invasive, high-energy, acoustic pressure shockwave technology. This innovative approach is applied in wound care, orthopedics, and other medical fields, setting SANUWAVE apart in a competitive landscape. The company's financial metrics, particularly its Return on Invested Capital (ROIC) and Weighted Average Cost of Capital (WACC), highlight its efficiency a ...

公司业务定位 - 公司是一家专注于罕见病创新疗法开发和商业化的专业制药公司 [1] - 公司致力于解决未满足的医疗需求并将新疗法推向市场 [1] - 主要竞争对手包括Aquestive Therapeutics、Fennec Pharmaceuticals、Eyenovia、Verrica Pharmaceuticals和Evelo Biosciences [1] 财务效率表现 - 公司投入资本回报率为-1.26% 加权平均资本成本为8.78% [2] - ROIC与WACC比率为-0.14 虽然为负值但优于同行 [2] - 该比率表明公司更接近产生与资本成本相匹配的回报 [2] 同业比较分析 - Aquestive Therapeutics的ROIC为-69.51% WACC为14.86% 比率为-4.68 [3] - Fennec Pharmaceuticals的ROIC为-27.37% WACC为7.50% 比率为-3.65 在同行中效率损失最小 [3] - Eyenovia的ROIC为-82.43% WACC为15.56% 比率为-5.30 [4] - Verrica Pharmaceuticals的ROIC为-166.93% WACC为17.86% 比率为-9.34 [4] - Evelo Biosciences的ROIC为-201.37% WACC为9.04% 比率为-22.28 效率最低 [4] 行业整体状况 - 所有公司均产生低于资本成本的回报 [3] - 公司相对表现优于同行 显示出改善财务效率的潜力 [5]

公司业务与行业定位 - STRATA Skin Sciences Inc 是一家专注于皮肤病治疗产品开发和商业化的医疗技术公司 利用激光技术提供创新解决方案 [1] - 公司在医疗保健领域与Sensus Healthcare Inc、Soleno Therapeutics Inc、SenesTech Inc及Xcel Brands Inc等企业存在竞争关系 [1] 财务绩效分析 - STRATA的投入资本回报率为-58.59% 加权平均资本成本为7.71% 导致ROIC与WACC比值为-7.60 表明公司未能产生超过资本成本的回报 [2] - 相比同行 Sensus Healthcare的ROIC为-4.47% WACC为10.28% ROIC/WACC比值为-0.44 为同业最高水平 显示其资本效率最接近盈亏平衡点 [3] - Soleno Therapeutics和SenesTech的ROIC/WACC比值分别为-13.40和-12.05 Xcel Brands该比值为-8.94 均显示资本管理效率存在重大挑战 [4] 行业比较结论 - 分析显示所有公司均面临无法产生超过资本成本回报的困境 [5] - Sensus Healthcare在资本效率管理方面表现相对优于同业 显示出更大的改善潜力 [3][5]

公司财务表现 - Karyopharm Therapeutics Inc (KPTI) 的投入资本回报率(ROIC)为-1634.05% 远低于其加权平均资本成本(WACC)16.41% 资本利用效率极低 [1][5] - Karyopharm的ROIC与WACC比值为-99.57 在同行中表现最差 [1] 同业比较分析 - MacroGenics Inc (MGNX) ROIC为-37.98% WACC为9.15% 比值为-4.15 资本利用效率明显优于Karyopharm [2][4] - Agios Pharmaceuticals Inc (AGIO) ROIC为-30.47% WACC为7.57% 比值为-4.02 资本利用状况同样远好于Karyopharm [4] - TG Therapeutics Inc (TGTX) ROIC为15.75% WACC为12.34% 比值为1.28 是唯一实现正回报且回报超过资本成本的公司 [2] - Heron Therapeutics Inc (HRTX) ROIC为0.82% WACC为6.57% 比值为0.12 回报略高于资本成本 [3] - Intra-Cellular Therapies Inc (ITCI) ROIC为-10.08% WACC为5.90% 比值为-1.71 虽为负值但远优于Karyopharm [3]